349 related articles for article (PubMed ID: 17165130)
1. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
[TBL] [Abstract][Full Text] [Related]
2. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
3. Role of runt-related transcription factor 2 in signal network of tumors as an inter-mediator.
Sun SS; Zhang L; Yang J; Zhou X
Cancer Lett; 2015 May; 361(1):1-7. PubMed ID: 25727319
[TBL] [Abstract][Full Text] [Related]
4. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
Wang DC; Wang HF; Yuan ZN
Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
[TBL] [Abstract][Full Text] [Related]
5. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
6. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
Javed A; Barnes GL; Pratap J; Antkowiak T; Gerstenfeld LC; van Wijnen AJ; Stein JL; Lian JB; Stein GS
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1454-9. PubMed ID: 15665096
[TBL] [Abstract][Full Text] [Related]
7. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional co-repressors of Runx2.
Westendorf JJ
J Cell Biochem; 2006 May; 98(1):54-64. PubMed ID: 16440320
[TBL] [Abstract][Full Text] [Related]
9. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
[TBL] [Abstract][Full Text] [Related]
10. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
12. Networks and hubs for the transcriptional control of osteoblastogenesis.
Lian JB; Stein GS; Javed A; van Wijnen AJ; Stein JL; Montecino M; Hassan MQ; Gaur T; Lengner CJ; Young DW
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):1-16. PubMed ID: 17051438
[TBL] [Abstract][Full Text] [Related]
13. Runx2: of bone and stretch.
Ziros PG; Basdra EK; Papavassiliou AG
Int J Biochem Cell Biol; 2008; 40(9):1659-63. PubMed ID: 17656144
[TBL] [Abstract][Full Text] [Related]
14. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.
Zhang X; Wu H; Dobson JR; Browne G; Hong D; Akech J; Languino LR; Stein GS; Lian JB
J Cell Biochem; 2015 Sep; 116(9):2098-108. PubMed ID: 25808168
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase co-repressor complex control of Runx2 and bone formation.
Jensen ED; Nair AK; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2007; 17(3):187-96. PubMed ID: 17725488
[TBL] [Abstract][Full Text] [Related]
16. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
17. Roles of Runx2 in Skeletal Development.
Komori T
Adv Exp Med Biol; 2017; 962():83-93. PubMed ID: 28299652
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
[TBL] [Abstract][Full Text] [Related]
19. Myeloma cell-derived Runx2 promotes myeloma progression in bone.
Trotter TN; Li M; Pan Q; Peker D; Rowan PD; Li J; Zhan F; Suva LJ; Javed A; Yang Y
Blood; 2015 Jun; 125(23):3598-608. PubMed ID: 25862559
[TBL] [Abstract][Full Text] [Related]
20. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]